| Item Type | Name |
|
Concept
|
Lymphoma, Large B-Cell, Diffuse
|
|
Concept
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma
|
|
Concept
|
Lymphoma, T-Cell
|
|
Concept
|
Hematopoietic Stem Cell Transplantation
|
|
Concept
|
Lymphoma, B-Cell
|
|
Concept
|
Programmed Cell Death 1 Receptor
|
|
Concept
|
Cord Blood Stem Cell Transplantation
|
|
Concept
|
Carcinoma, Renal Cell
|
|
Concept
|
Granulocyte Precursor Cells
|
|
Concept
|
Stem Cell Transplantation
|
|
Concept
|
Leukemia, Lymphocytic, Chronic, B-Cell
|
|
Concept
|
Cell Count
|
|
Academic Article
|
Induction chemotherapy before autologous stem cell transplantation for symptomatic plasma cell myeloma - does it matter?
|
|
Academic Article
|
Clinical and safety profile of high-dose interleukin-2 treatment in elderly patients with metastatic melanoma and renal cell carcinoma.
|
|
Academic Article
|
Impact of cachexia on outcomes in aggressive lymphomas.
|
|
Academic Article
|
Allogeneic transplantation provides durable remission in a subset of DLBCL patients relapsing after autologous transplantation.
|
|
Academic Article
|
Efficacy of High-Dose Therapy and Autologous Hematopoietic Cell Transplantation in Gray Zone Lymphoma: A US Multicenter Collaborative Study.
|
|
Academic Article
|
Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission.
|
|
Academic Article
|
Myeloablative vs reduced-intensity conditioning allogeneic hematopoietic cell transplantation for chronic myeloid leukemia.
|
|
Academic Article
|
Ocular Graft-versus-Host Disease after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation.
|
|
Academic Article
|
Ocular graft-versus-host disease after hematopoietic cell transplantation: Expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT.
|
|
Academic Article
|
Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT.
|
|
Academic Article
|
Non-Graft-versus-Host Disease Ocular Complications after Hematopoietic Cell Transplantation: Expert Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and the Transplant Complications Working Party of the European Society for Blood and Marrow Transplantation.
|
|
Academic Article
|
Correction: Non-GVHD ocular complications after hematopoietic cell transplantation: expert review from the Late Effects and Quality of Life Working Committee of the CIBMTR and Transplant Complications Working Party of the EBMT.
|
|
Academic Article
|
Complications of Stem Cell Transplantation that Affect Infections in Stem Cell Transplant Recipients, with Analogies to Patients with Hematologic Malignancies.
|
|
Academic Article
|
Outcomes of haploidentical vs matched sibling transplantation for acute myeloid leukemia in first complete remission.
|
|
Academic Article
|
Necessity for treatment of steroid refractory severe GIT GVHD: patience of providers.
|
|
Academic Article
|
Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research.
|
|
Academic Article
|
Outcomes in patients with aggressive B-cell non-Hodgkin lymphoma after intensive frontline treatment failure.
|
|
Academic Article
|
Erythroid differentiation of myeloblast induced by gilteritinib in relapsed FLT3-ITD-positive acute myeloid leukemia.
|
|
Academic Article
|
Allogeneic transplantation in elderly patients =65 years with non-Hodgkin lymphoma: a time-trend analysis.
|
|
Academic Article
|
The Role of Donor Lymphocyte Infusion (DLI) in Post-Hematopoietic Cell Transplant (HCT) Relapse for Chronic Myeloid Leukemia (CML) in the Tyrosine Kinase Inhibitor (TKI) Era.
|
|
Academic Article
|
DLBCL After Allogeneic HCT in a Patient With Transformed DLBCL: Does It Matter Whether Relapse or PTLD?
|
|
Academic Article
|
Late effects after ablative allogeneic stem cell transplantation for adolescent and young adult acute myeloid leukemia.
|
|
Academic Article
|
Biosimilar infliximab administration for the management of acute graft-versus-host disease.
|
|
Academic Article
|
Significance of isolated deletion (20q) in donor cells after allogeneic hematopoietic cell transplantation.
|
|
Academic Article
|
Allogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell lymphoma: a CIBMTR analysis.
|
|
Academic Article
|
Checkpoint blockade treatment sensitises relapsed/refractory non-Hodgkin lymphoma to subsequent therapy.
|
|
Academic Article
|
Calcineurin-inhibitor induced pain syndrome after stem cell transplant.
|
|
Academic Article
|
Tissue mast cell counts may be associated with decreased severity of gastrointestinal acute GVHD and nonrelapse mortality.
|
|
Academic Article
|
Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report.
|
|
Academic Article
|
Prognostic Score and Cytogenetic Risk Classification for Chronic Lymphocytic Leukemia Patients: Center for International Blood and Marrow Transplant Research Report.
|
|
Academic Article
|
A Personalized Prediction Model for Outcomes after Allogeneic Hematopoietic Cell Transplant in Patients with Myelodysplastic Syndromes.
|
|
Academic Article
|
COVID-19 infection in hematopoietic cell transplantation: age, time from transplant and steroids matter.
|
|
Academic Article
|
Core-binding factor acute myeloid leukemia with inv(16): Older age and high white blood cell count are risk factors for treatment failure.
|
|
Academic Article
|
Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myelogenous Leukemia and Myelodysplastic Syndromes with Low/Intermediate but not High Disease Risk Index: A Center for International Blood and Marrow Transplant Research Study.
|
|
Academic Article
|
Outcomes of rituximab-BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation.
|
|
Academic Article
|
Impact of type of reduced-intensity conditioning regimen on the outcomes of allogeneic haematopoietic cell transplantation in classical Hodgkin lymphoma.
|
|
Academic Article
|
Allogeneic transplantation after PD-1 blockade for classic Hodgkin lymphoma.
|
|
Academic Article
|
Human Herpesvirus-6 Infection and Calcineurin Inhibitor Pain Syndrome Interaction after Umbilical Cord Blood Transplant.
|
|
Academic Article
|
Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation.
|
|
Academic Article
|
Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United States.
|
|
Academic Article
|
Correction to: Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation.
|
|
Academic Article
|
Successful Triplet Pregnancy Post-Allogeneic Stem Cell Transplant in a Patient With Doxorubicin-Induced Cardiomyopathy.
|
|
Academic Article
|
Impact of cytogenetic abnormalities on outcomes of adult Philadelphia-negative acute lymphoblastic leukemia after allogeneic hematopoietic stem cell transplantation: a study by the Acute Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research.
|
|
Academic Article
|
Role of Physical Activity and Cardiac?Rehabilitation in Patients Undergoing?Hematopoietic Stem?Cell?Transplantation.
|
|
Academic Article
|
Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improve Transplantation Outcomes in Older Patients with Myelodysplastic Syndromes.
|
|
Academic Article
|
Allogeneic Transplantation to Treat Therapy-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in Adults.
|
|
Academic Article
|
Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma-type Richter syndrome.
|
|
Academic Article
|
Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia.
|
|
Academic Article
|
Risk classification at diagnosis predicts post-HCT outcomes in intermediate-, adverse-risk, and KMT2A-rearranged AML.
|
|
Academic Article
|
An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis.
|
|
Academic Article
|
Maintenance therapy after second autologous hematopoietic cell transplantation for multiple myeloma. A CIBMTR analysis.
|
|
Academic Article
|
Male-Specific Late Effects in Adult Hematopoietic Cell Transplantation Recipients: A Systematic Review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation.
|
|
Academic Article
|
Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors.
|
|
Academic Article
|
Correction to: An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis.
|
|
Academic Article
|
Male-specific late effects in adult hematopoietic cell transplantation recipients: a systematic review from the Late Effects and Quality of Life Working Committee of the Center for International Blood and Marrow Transplant Research and Transplant Complications Working Party of the European Society of Blood and Marrow Transplantation.
|
|
Academic Article
|
Transplantation provides superior survival high risk myeloid malignancies in older patients.
|
|
Academic Article
|
Autologous stem cell transplantation in a patient with scleromyxedema.
|
|
Academic Article
|
Scedosporium infection disseminated "from toe to head" in allogeneic stem cell transplant recipient: a case report.
|
|
Academic Article
|
The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis.
|
|
Academic Article
|
Outcomes after autologous hematopoietic cell transplantation in POEMS syndrome and comparison with multiple myeloma.
|
|
Academic Article
|
ASTCT Clinical Practice Recommendations for Transplantation and Cellular Therapies in Diffuse Large B Cell Lymphoma.
|
|
Academic Article
|
Post-transplantation cyclophosphamide is associated with increased bacterial infections.
|
|
Academic Article
|
Association of ABO mismatch with the outcomes of allogeneic hematopoietic cell transplantation for acute leukemia.
|
|
Academic Article
|
Impact of pre-transplant induction and consolidation cycles on AML allogeneic transplant outcomes: a CIBMTR analysis in 3113 AML patients.
|
|
Academic Article
|
Association between the choice of the conditioning regimen and outcomes of allogeneic hematopoietic cell transplantation for myelofibrosis.
|
|
Academic Article
|
Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis.
|
|
Academic Article
|
A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis.
|
|
Academic Article
|
Myeloablative TBI is associated with increased risk of pulmonary GVHD in patients undergoing allogeneic hematopoietic stem cell transplant.
|
|
Academic Article
|
Survival following allogeneic transplant in patients with myelofibrosis.
|
|
Academic Article
|
Incidence and Impact of Fungal Infections in Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis and Haploidentical Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis.
|
|
Academic Article
|
Cardiovascular Risk Stratification of Patients Undergoing Hematopoietic Stem Cell Transplantation: The CARE-BMT Risk Score.
|